In vitro activity of terbinafine against medically important non-dermatophyte species of filamentous fungi

被引:40
作者
Garcia-Effron, G [1 ]
Gomez-Lopez, A [1 ]
Mellado, E [1 ]
Monzon, A [1 ]
Rodriguez-Tudela, JL [1 ]
Cuenca-Estrella, M [1 ]
机构
[1] Inst Salud Carlos III, Ctr Nacl Microbiol, Serv Micol, Madrid 28220, Spain
关键词
Aspergillus spp; Spanish filamentous fungi; allylamines; antifungals;
D O I
10.1093/jac/dkh228
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: The activity in vitro of terbinafine against 442 clinical isolates of several species of filamentous fungi was analysed. Methods: A broth microdilution test was carried out following the National Committee for Clinical Laboratory Standards reference method, with modifications described previously. Results: The geometric mean (GM) of MICs of terbinafine for non-Aspergillus fumigatus species was 0.24 mg/L whereas the GM for A. fumigatus rose as far as 2.92 mg/L. Terbinafine showed a very strong activity in vitro against Penicillium spp., Paecilomyces spp., Trichoderma spp., Acremonium spp. and Arthrographis spp. with GMs <1 mg/L. However, some species such as Scedosporium spp., Fusarium spp., Scopulariopsis brevicaulis, and most of Mucorales exhibited high MICs of the allylamine with GMs greater than or equal to 4 mg/L. Conclusions: Overall, the GM of MICs of terbinafine was 1.57 mg/L, but significant differences in susceptibilities were seen between genera and species.
引用
收藏
页码:1086 / 1089
页数:4
相关论文
共 14 条
  • [1] Paecilomyces lilacinus infection in a heart transplant recipient and successful treatment with terbinafine
    Clark, NM
    [J]. CLINICAL INFECTIOUS DISEASES, 1999, 28 (05) : 1169 - 1170
  • [2] Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents
    Cuenca-Estrella, M
    Gomez-Lopez, A
    Mellado, E
    Buitrago, MJ
    Monzón, A
    Rodriguez-Tudela, JL
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (07) : 2339 - 2341
  • [3] Influence of glucose supplementation and inoculum size on growth kinetics and antifungal susceptibility testing of Candida spp.
    Cuenca-Estrella, M
    Díaz-Guerra, TM
    Mellado, E
    Rodríguez-Tudela, JL
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (02) : 525 - 532
  • [4] Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection
    Denning, DW
    Radford, SA
    Oakley, KL
    Hall, L
    Johnson, EM
    Warnock, DW
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (03) : 401 - 414
  • [5] In vitro activities of three licensed antifungal agents against Spanish clinical isolates of Aspergillus spp.
    Gomez-Lopez, A
    Garcia-Effron, G
    Mellado, E
    Monzon, A
    Rodriguez-Tudela, JL
    Cuenca-Estrella, M
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (10) : 3085 - 3088
  • [6] Hay RJ, 1999, BRIT J DERMATOL, V141, P36
  • [7] Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine
    Howden, BP
    Slavin, MA
    Schwarer, AP
    Mijch, AM
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2003, 22 (02) : 111 - 113
  • [8] An evaluation of the in vitro activity of terbinafine
    Jessup, CJ
    Ryder, NS
    Ghannoum, MA
    [J]. MEDICAL MYCOLOGY, 2000, 38 (02) : 155 - 159
  • [9] In vitro activities of terbinafine against Aspergillus species in comparison with those of itraconazole and amphotericin B
    Moore, CB
    Walls, CM
    Denning, DW
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) : 1882 - 1885
  • [10] Pfaller M.A., 2002, REFERENCE METHOD BRO